Left Ventricular Morphology and Function in Normotensive, Metabolically Healthy Obese Individuals without Fatty Liver Disease.

Background: Obesity is one of the major risk factors for the development of heart failure (HF), although the exact underlying mechanism remains unclear. In the clinical setting, assessing the impact of obesity on the cardiovascular system is difficult due to comorbidities.

Objectives: The purpose of this study was to evaluate an independent influence of obesity on the left ventricular (LV) morphology and function.

Anemia, Iron Deficiency, and Iron Regulators in Pancreatic Ductal Adenocarcinoma Patients: A Comprehensive Analysis.

Anemia and iron deficiency (ID) are common complications in patients with pancreatic ductal adenocarcinoma (PDAC), but their underlying causes remain unclear. This study investigated the incidence and characteristics of anemia and micronutrient deficiencies in PDAC patients before initiating chemotherapy. A total of 103 PDAC patients were included, comprising 67 in the palliative and 36 in the adjuvant groups.

and Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery.

The severity of hepatic steatosis is modulated by genetic variants, such as patatin-like phospholipase domain containing 3 () rs738409, transmembrane 6 superfamily member 2 () rs58542926, and membrane-bound O-acyltransferase domain containing 7 () rs641738. Recently, mitochondrial amidoxime reducing component 1 () rs2642438 and hydroxysteroid 17-beta dehydrogenase 13 () rs72613567 polymorphisms were shown to have protective effects on liver diseases. Here, we evaluate these variants in patients undergoing bariatric surgery.

Ultrasound- and biomarker-based assessment of hepatic steatosis in patients with severe obesity.

Introduction: Nonalcoholic fatty liver disease (NAFLD) is a common liver abnormality, but its noninvasive diagnosis in patients with severe obesity remains difficult.

Objectives: Our aim was to investigate the usefulness of the ultrasound‑based hepatorenal index (HRI) technique and 2 biomarker‑based methods, including the hepatic steatosis index (HSI) and NAFLD logit score for the diagnosis of NAFLD in patients referred for bariatric surgery.

Patients And Methods: A total of 162 patients, including 106 with NAFLD, admitted for bariatric surgery participated in the study.